Xia Xiaotong, Wu Jianmei, Zhang Jinhua
Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
Int J Clin Pharm. 2018 Dec;40(6):1420-1429. doi: 10.1007/s11096-018-0731-8. Epub 2018 Oct 26.
Background Patients using oral anticoagulants are prone both to thrombus from insufficient anticoagulant therapy and to bleeding by overmedication, so there is a need for further exploring. Aim of the review To assess the effect of online management (using electronic communication such as smartphone), and hospital management on the outcome of patients on long-term anticoagulant therapy, and to explore an appropriate anticoagulation management model. Method Studies published in English prior to July 2017 were retrieved from PubMed, EMBASE, Web of Science, and the Cochrane Library. Two researchers screened the literature independently, extracted the data and evaluated the methodological quality of the included studies. Meta-analysis was conducted using RevMan 5.3 software. The publication bias analysis was evaluated. Results A total of ten studies met the inclusion criteria, covering 16,915 patients. Of these, 8260 cases formed the online anticoagulation management group, and the other 8655 cases the hospital anticoagulant management group. There were no significant differences between the management models for time in therapeutic range, incidence of major or minor bleeding events, thromboembolic events, or warfarin-related emergency department visits. However, online management was associated with fewer warfarin-related hospital admissions than hospital management (odds ratio: 0.47, 95% confidence interval [0.30, 0.73]; P = 0.0009). Conclusion The online management of anticoagulant therapy was not inferior to hospital management, and may provide more convenient, higher quality anticoagulant therapy services for patients.
使用口服抗凝剂的患者既容易因抗凝治疗不足而形成血栓,又容易因用药过量而出血,因此需要进一步探索。综述目的:评估在线管理(使用智能手机等电子通信方式)和医院管理对长期接受抗凝治疗患者结局的影响,并探索合适的抗凝管理模式。方法:从PubMed、EMBASE、Web of Science和Cochrane图书馆检索2017年7月之前发表的英文研究。两名研究人员独立筛选文献、提取数据并评估纳入研究的方法学质量。使用RevMan 5.3软件进行荟萃分析。评估发表偏倚分析。结果:共有10项研究符合纳入标准,涵盖16915例患者。其中,8260例组成在线抗凝管理组,另外8655例组成医院抗凝管理组。在治疗范围内的时间、严重或轻微出血事件的发生率、血栓栓塞事件或华法林相关急诊就诊方面,管理模式之间没有显著差异。然而,与医院管理相比,在线管理与华法林相关住院次数较少相关(优势比:0.47,95%置信区间[0.30, 0.73];P = 0.0009)。结论:抗凝治疗的在线管理并不逊色于医院管理,并且可能为患者提供更便捷、更高质量的抗凝治疗服务。